Home › Head and Neck Squamous Cell Carcinoma › Oregon › Beaverton
Head and Neck Squamous Cell Carcinoma clinical trials in Beaverton, OR
3 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Beaverton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
RecruitingPhase 2
- Providence Newberg Medical Center, Newberg · 15 mi away
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Providence Newberg Medical Center, Newberg · 15 mi away
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Providence Newberg Medical Center, Newberg · 15 mi away
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX49 studies
- Nashville, TN43 studies
- Los Angeles, CA43 studies
- Boston, MA42 studies
- New York City, NY42 studies
- St. Louis, MO32 studies
- Chicago, IL29 studies
- Arlington, VA29 studies
- Philadelphia, PA25 studies
- Pittsburgh, PA23 studies
- Atlanta, GA22 studies
- New Haven, CT22 studies
Other studies in Beaverton
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer8 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Prostate Cancer5 studies
- Colorectal Cancer5 studies
- Bladder Cancer4 studies
- Endometrial Cancer4 studies
- Cancer (all types)3 studies
- Acute Myeloid Leukemia3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.